GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow GEHC
GE HealthCare Technologies Inc. (GEHC) Shares outstanding
GE HealthCare Technologies Inc.'s shares outstanding at the end of fiscal 2025 was $458.0M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $454.0M. Over the past ten years it has ranged from $454.0M (fiscal 2022) to $459.0M (fiscal 2024); the current reading is higher than 86% of that period. GE HealthCare Technologies Inc. ranks 7th of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $458.0M | (0.22%) |
| FY2024 | $459.0M | 0.22% |
| FY2023 | $458.0M | 0.88% |
| FY2022 | $454.0M | 0.00% |
| FY2021 | $454.0M | (0.22%) |
| FY2020 | $455.0M | 0.00% |
| FY2019 | $455.0M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $454.0M | (0.66%) |
| Mar 2026 | $457.0M | (0.22%) |
| Dec 2025 | $458.0M | 0.22% |
| Sep 2025 | $457.0M | (0.22%) |
| 14 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| BSX Boston Scientific Corporation compare | $1.5B |
| PHG Koninklijke Philips N.V. compare | $968.6M |
| EW Edwards Lifesciences Corporation compare | $577.6M |
| GEHC GE HealthCare Technologies Inc. | $454.0M |
| SNN Smith & Nephew SNATS, Inc. compare | $449.4M |
| DXCM DexCom, Inc. compare | $390.1M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $192.8M |
| STE STERIS plc compare | $97.9M |
| PEN Penumbra, Inc. compare | $39.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on GEHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement